Effects of exenatide plus rosiglitazone on beta-cell function and insulin sensitivity in subjects with type 2 diabetes on metformin.

Diabetes Care
Ralph A DeFronzoLeonard C Glass

Abstract

Study the effects of exenatide (EXE) plus rosiglitazone (ROSI) on beta-cell function and insulin sensitivity using hyperglycemic and euglycemic insulin clamp techniques in participants with type 2 diabetes on metformin. In this 20-week, randomized, open-label, multicenter study, participants (mean age, 56 +/- 10 years; weight, 93 +/- 16 kg; A1C, 7.8 +/- 0.7%) continued their metformin regimen and received either EXE 10 microg b.i.d. (n = 45), ROSI 4 mg b.i.d. (n = 45), or EXE 10 microg b.i.d. + ROSI 4 mg b.i.d. (n = 47). Seventy-three participants underwent clamp procedures to quantitate insulin secretion and insulin sensitivity. RESULTS A1C declined in all groups (P < 0.05), but decreased most with EXE+ROSI (EXE+ROSI, -1.3 +/- 0.1%; ROSI, -1.0 +/- 0.1%, EXE, -0.9 +/- 0.1%; EXE+ROSI vs. EXE or ROSI, P < 0.05). ROSI resulted in weight gain, while EXE and EXE+ROSI resulted in weight loss (EXE, -2.8 +/- 0.5 kg; EXE+ROSI, -1.2 +/- 0.5 kg; ROSI, + 1.5 +/- 0.5 kg; P < 0.05 between and within all groups). At week 20, 1st and 2nd phase insulin secretion was significantly higher in EXE and EXE+ROSI versus ROSI (both P < 0.05). Insulin sensitivity (M value) was significantly higher in EXE+ROSI versus EXE (P = 0.014). Therapy with EXE+ROS...Continue Reading

References

Dec 1, 1991·The Journal of Clinical Endocrinology and Metabolism·R A DeFronzoD C Simonson
Oct 1, 1990·Metabolism: Clinical and Experimental·D JallutJ P Felber
Aug 24, 1999·Annals of Internal Medicine·R A DeFronzo
Jun 7, 2000·Diabetes Care·T VilsbøllJ J Holst
Mar 13, 2002·The Journal of Clinical Endocrinology and Metabolism·Josephine M EganDariush Elahi
Dec 11, 2003·Diabetologia·A GastaldelliUNKNOWN San Antonio metabolism study
Oct 16, 2004·The Journal of Clinical Endocrinology and Metabolism·Ele FerranniniRalph A DeFronzo
Nov 16, 2006·American Journal of Physiology. Endocrinology and Metabolism·Amalia GastaldelliRalph A DeFronzo
Dec 6, 2006·The New England Journal of Medicine·Steven E KahnUNKNOWN ADOPT Study Group
Mar 14, 2007·Endocrine Reviews·Bernardo L Wajchenberg
Apr 26, 2008·Endocrine Reviews·Stephanie T PageWilliam J Bremner

❮ Previous
Next ❯

Citations

Feb 2, 2013·Current Diabetes Reports·Kathleen A Page, Tamar Reisman
Aug 1, 2012·Diabetes Technology & Therapeutics·Krystal L EdwardsBrian K Irons
Dec 15, 2010·BMC Endocrine Disorders·Deepson S ShyangdanNorman R Waugh
Dec 22, 2012·International Journal of Pediatric Endocrinology·Chirag KapadiaUNKNOWN Drugs and Therapeutics Committee of the Pediatric Endocrine Society
Jan 1, 2011·The Review of Diabetic Studies : RDS·Angela D MazzaSteven R Smith
May 17, 2011·Acta Diabetologica·Gian Paolo FadiniAngelo Avogaro
Oct 5, 2010·Journal of Obesity·Vicky Cheng, Sangeeta R Kashyap
Feb 18, 2016·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Sheena KayaniyilBernt Kartman
Oct 30, 2010·Expert Opinion on Biological Therapy·Michael J Riedel, Timothy J Kieffer
Sep 1, 2011·Diabetes Research and Clinical Practice·Daniel H van Raalte, Michaela Diamant
Mar 23, 2012·Journal of Clinical Pharmacy and Therapeutics·S Cornell
Aug 21, 2013·International Journal of Clinical Practice·S Mudaliar
Jul 20, 2013·Cardiovascular Therapeutics·Daniel Lorber
Nov 5, 2014·International Journal of Clinical Practice·M E RotzT F Thomas
Mar 27, 2012·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Richard PencekJames Malone
Jan 22, 2013·Diabetes Research and Clinical Practice·Susan Herzlinger, Edward S Horton
Dec 3, 2014·The Medical Clinics of North America·Farah Meah, Rattan Juneja
Aug 2, 2013·Diabetes Care·Ralph A DeFronzoMuhammad Abdul-Ghani
Jun 21, 2016·Diabetes Research and Clinical Practice·Crystal Man Ying LeeStephen Colagiuri
Aug 10, 2016·Journal of Diabetes and Its Complications·Jia LiuGuang Wang

❮ Previous
Next ❯

Software Mentioned

SAS

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.